-
1
-
-
77649179672
-
Eicosanoids and cancer
-
Wang, D., and Dubois, R. N. (2010) Eicosanoids and cancer. Nat. Rev. Cancer 10, 181-193
-
(2010)
Nat. Rev. Cancer
, vol.10
, pp. 181-193
-
-
Wang, D.1
Dubois, R.N.2
-
2
-
-
0033594963
-
Identification of human prostaglandin e synthase: A microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target
-
Jakobsson, P.J., Thorén, S., Morgenstern, R., and Samuelsson, B. (1999) Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc. Natl. Acad. Sci. U.S.A. 96, 7220-7225
-
(1999)
Proc. Natl. Acad. Sci. U.S.A.
, vol.96
, pp. 7220-7225
-
-
Jakobsson, P.J.1
Thorén, S.2
Morgenstern, R.3
Samuelsson, B.4
-
3
-
-
0034692689
-
Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2
-
Murakami, M., Naraba, H., Tanioka, T., Semmyo, N., Nakatani, Y., Kojima, F., Ikeda, T., Fueki, M., Ueno, A., Oh, S., and Kudo, I. (2000) Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem. 275, 32783-32792
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 32783-32792
-
-
Murakami, M.1
Naraba, H.2
Tanioka, T.3
Semmyo, N.4
Nakatani, Y.5
Kojima, F.6
Ikeda, T.7
Fueki, M.8
Ueno, A.9
Oh, S.10
Kudo, I.11
-
4
-
-
0036468899
-
Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer
-
Ristimäki, A., Sivula, A., Lundin, J., Lundin, M., Salminen, T., Haglund, C., Joensuu, H., and Isola, J. (2002) Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res. 62, 632-635
-
(2002)
Cancer Res.
, vol.62
, pp. 632-635
-
-
Ristimäki, A.1
Sivula, A.2
Lundin, J.3
Lundin, M.4
Salminen, T.5
Haglund, C.6
Joensuu, H.7
Isola, J.8
-
5
-
-
0031924535
-
COX-2 inhibitors for colorectal cancer
-
Elder, D. J., and Paraskeva, C. (1998) COX-2 inhibitors for colorectal cancer. Nat. Med. 4, 392-393
-
(1998)
Nat. Med.
, vol.4
, pp. 392-393
-
-
Elder, D.J.1
Paraskeva, C.2
-
6
-
-
33645527575
-
Prostaglandin e receptor EP4 antagonism inhibits breast cancer metastasis
-
Ma, X., Kundu, N., Rifat, S., Walser, T., and Fulton, A. M. (2006) Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis. Cancer Res. 66, 2923-2927
-
(2006)
Cancer Res.
, vol.66
, pp. 2923-2927
-
-
Ma, X.1
Kundu, N.2
Rifat, S.3
Walser, T.4
Fulton, A.M.5
-
7
-
-
83855162802
-
The role of the EP receptors for prostaglandin E2 in skin and skin cancer
-
Rundhaug, J. E., Simper, M. S., Surh, I., and Fischer, S. M. (2011) The role of the EP receptors for prostaglandin E2 in skin and skin cancer. Cancer Metastasis Rev. 30, 465-480
-
(2011)
Cancer Metastasis Rev.
, vol.30
, pp. 465-480
-
-
Rundhaug, J.E.1
Simper, M.S.2
Surh, I.3
Fischer, S.M.4
-
8
-
-
80053181688
-
Prostaglandin E2 regulates renal cell carcinoma invasion through the EP4 receptor-Rap GTPase signal transduction pathway
-
Wu, J., Zhang, Y., Frilot, N., Kim, J. I., Kim, W. J., and Daaka, Y. (2011) Prostaglandin E2 regulates renal cell carcinoma invasion through the EP4 receptor-Rap GTPase signal transduction pathway. J. Biol. Chem. 286, 33954-33962
-
(2011)
J. Biol. Chem.
, vol.286
, pp. 33954-33962
-
-
Wu, J.1
Zhang, Y.2
Frilot, N.3
Kim, J.I.4
Kim, W.J.5
Daaka, Y.6
-
9
-
-
0037454960
-
Host prostaglandin E2-EP3 signaling regulates tumor-associated angiogenesis and tumor growth
-
Amano, H., Hayashi, I., Endo, H., Kitasato, H., Yamashina, S., Maruyama, T., Kobayashi, M., Satoh, K., Narita, M., Sugimoto, Y., Murata, T., Yoshimura, H., Narumiya, S., and Majima, M. (2003) Host prostaglandin E2-EP3 signaling regulates tumor-associated angiogenesis and tumor growth. J. Exp. Med. 197, 221-232
-
(2003)
J. Exp. Med.
, vol.197
, pp. 221-232
-
-
Amano, H.1
Hayashi, I.2
Endo, H.3
Kitasato, H.4
Yamashina, S.5
Maruyama, T.6
Kobayashi, M.7
Satoh, K.8
Narita, M.9
Sugimoto, Y.10
Murata, T.11
Yoshimura, H.12
Narumiya, S.13
Majima, M.14
-
10
-
-
84856888800
-
Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4
-
Holt, D. M., Ma, X., Kundu, N., and Collin, P. D., and Fulton, A. M. (2012) Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4. J. Immunother. 35, 179-188
-
(2012)
J. Immunother.
, vol.35
, pp. 179-188
-
-
Holt, D.M.1
Ma, X.2
Kundu, N.3
Collin, P.D.4
Fulton, A.M.5
-
11
-
-
0037462917
-
Role of prostaglandin e produced by osteoblasts in osteolysis due to bone metastasis
-
Ohshiba, T., Miyaura, C., and Ito, A. (2003) Role of prostaglandin E produced by osteoblasts in osteolysis due to bone metastasis. Biochem. Biophys. Res. Commun. 300, 957-964
-
(2003)
Biochem. Biophys. Res. Commun.
, vol.300
, pp. 957-964
-
-
Ohshiba, T.1
Miyaura, C.2
Ito, A.3
-
12
-
-
33846427739
-
Prostaglandin e receptor EP4 antagonist suppresses osteolysis due to bone metastasis of mouse malignant melanoma cells
-
Takita, M., Inada, M., Maruyama, T., and Miyaura, C. (2007) Prostaglandin E receptor EP4 antagonist suppresses osteolysis due to bone metastasis of mouse malignant melanoma cells. FEBS Lett. 581, 565-571
-
(2007)
FEBS Lett.
, vol.581
, pp. 565-571
-
-
Takita, M.1
Inada, M.2
Maruyama, T.3
Miyaura, C.4
-
13
-
-
0036604215
-
Lipopolysaccharide-dependent prostaglandin E2 production is regulated by the glutathione-dependent prostaglandin E2 synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway
-
Uematsu, S., Matsumoto, M., Takeda, K., and Akira, S. (2002) Lipopolysaccharide-dependent prostaglandin E2 production is regulated by the glutathione-dependent prostaglandin E2 synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway. J. Immunol. 168, 5811-5816
-
(2002)
J. Immunol.
, vol.168
, pp. 5811-5816
-
-
Uematsu, S.1
Matsumoto, M.2
Takeda, K.3
Akira, S.4
-
14
-
-
33746214778
-
Membrane-bound prostaglandin e synthase-1-mediated prostaglandin E2 production by osteoblast plays a critical role in lipopolysaccharide-induced bone loss associated with inflammation
-
Inada, M., Matsumoto, C., Uematsu, S., Akira, S., and Miyaura, C. (2006) Membrane-bound prostaglandin E synthase-1-mediated prostaglandin E2 production by osteoblast plays a critical role in lipopolysaccharide-induced bone loss associated with inflammation. J. Immunol. 177, 1879-1885
-
(2006)
J. Immunol.
, vol.177
, pp. 1879-1885
-
-
Inada, M.1
Matsumoto, C.2
Uematsu, S.3
Akira, S.4
Miyaura, C.5
-
15
-
-
0030714605
-
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
-
Anderson, D.M., Maraskovsky, E., Billingsley, W.L., Dougall, W.C., Tometsko, M.E., Roux, E.R., Teepe, M.C., DuBose, R.F., Cosman, D., and Galibert, L. (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390, 175-179
-
(1997)
Nature
, vol.390
, pp. 175-179
-
-
Anderson, D.M.1
Maraskovsky, E.2
Billingsley, W.L.3
Dougall, W.C.4
Tometsko, M.E.5
Roux, E.R.6
Teepe, M.C.7
DuBose, R.F.8
Cosman, D.9
Galibert, L.10
-
16
-
-
14444272043
-
TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells
-
Wong, B. R., Rho, J., Arron, J., Robinson, E., Orlinick, J., Chao, M., Kalachikov, S., Cayani, E., Bartlett, F. S., 3rd, Frankel, W. N., Lee, S. Y., and Choi, Y. (1997) TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272, 25190-25194
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 25190-25194
-
-
Wong, B.R.1
Rho, J.2
Arron, J.3
Robinson, E.4
Orlinick, J.5
Chao, M.6
Kalachikov, S.7
Cayani, E.8
Bartlett, F.S.9
Frankel, W.N.10
Lee, S.Y.11
Choi, Y.12
-
17
-
-
0032540319
-
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
-
Lacey, D. L., Timms, E., Tan, H. L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., Hsu, H., Sullivan, J., Hawkins, N., Davy, E., Capparelli, C., Eli, A., Qian, Y. X., Kaufman, S., Sarosi, I., Shalhoub, V., Senaldi, G., Guo, J., Delaney, J., and Boyle, W. J. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176
-
(1998)
Cell
, vol.93
, pp. 165-176
-
-
Lacey, D.L.1
Timms, E.2
Tan, H.L.3
Kelley, M.J.4
Dunstan, C.R.5
Burgess, T.6
Elliott, R.7
Colombero, A.8
Elliott, G.9
Scully, S.10
Hsu, H.11
Sullivan, J.12
Hawkins, N.13
Davy, E.14
Capparelli, C.15
Eli, A.16
Qian, Y.X.17
Kaufman, S.18
Sarosi, I.19
Shalhoub, V.20
Senaldi, G.21
Guo, J.22
Delaney, J.23
Boyle, W.J.24
more..
-
18
-
-
0032584208
-
Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
-
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K., Udagawa, N., Takahashi, N., and Suda, T. (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. U.S.A. 95, 3597-3602
-
(1998)
Proc. Natl. Acad. Sci. U.S.A.
, vol.95
, pp. 3597-3602
-
-
Yasuda, H.1
Shima, N.2
Nakagawa, N.3
Yamaguchi, K.4
Kinosaki, M.5
Mochizuki, S.6
Tomoyasu, A.7
Yano, K.8
Goto, M.9
Murakami, A.10
Tsuda, E.11
Morinaga, T.12
Higashio, K.13
Udagawa, N.14
Takahashi, N.15
Suda, T.16
-
19
-
-
0035360265
-
Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis
-
Morony, S., Capparelli, C., Sarosi, I., Lacey, D. L., Dunstan, C. R., and Kostenuik, P. J. (2001) Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis. Cancer Res. 61, 4432-4436
-
(2001)
Cancer Res.
, vol.61
, pp. 4432-4436
-
-
Morony, S.1
Capparelli, C.2
Sarosi, I.3
Lacey, D.L.4
Dunstan, C.R.5
Kostenuik, P.J.6
-
20
-
-
0344844468
-
Soluble receptor activator of nuclear factor κb Fc diminishes prostate cancer progression in bone
-
Zhang, J., Dai, J., Yao, Z., Lu, Y., Dougall, W., and Keller, E. T. (2003) Soluble receptor activator of nuclear factor κB Fc diminishes prostate cancer progression in bone. Cancer Res. 63, 7883-7890
-
(2003)
Cancer Res.
, vol.63
, pp. 7883-7890
-
-
Zhang, J.1
Dai, J.2
Yao, Z.3
Lu, Y.4
Dougall, W.5
Keller, E.T.6
-
21
-
-
78650397541
-
Clinical development of anti-RANKL therapies for treatment and prevention of bone metastasis
-
Lipton, A., and Goessl, C. (2011) Clinical development of anti-RANKL therapies for treatment and prevention of bone metastasis. Bone 48, 96-99
-
(2011)
Bone
, vol.48
, pp. 96-99
-
-
Lipton, A.1
Goessl, C.2
-
22
-
-
0038485707
-
Role of RANKLinduced osteoclast formation and MMP-dependent matrix degradation in bone destruction by breast cancer metastasis
-
Ohshiba, T., Miyaura, C., Inada, M., and Ito, A. (2003) Role of RANKLinduced osteoclast formation and MMP-dependent matrix degradation in bone destruction by breast cancer metastasis. Br. J. Cancer 88, 1318-1326
-
(2003)
Br. J. Cancer
, vol.88
, pp. 1318-1326
-
-
Ohshiba, T.1
Miyaura, C.2
Inada, M.3
Ito, A.4
-
23
-
-
34249729416
-
Prostaglandin e receptors
-
Sugimoto, Y., and Narumiya, S. (2007) Prostaglandin E receptors. J. Biol. Chem. 282, 11613-11617
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 11613-11617
-
-
Sugimoto, Y.1
Narumiya, S.2
-
24
-
-
0034733567
-
Impaired bone resorption to prostaglandin E2 in prostaglandin e receptor EP4-knockout mice
-
Miyaura, C., Inada, M., Suzawa, T., Sugimoto, Y., Ushikubi, F., Ichikawa, A., Narumiya, S., and Suda, T. (2000) Impaired bone resorption to prostaglandin E2 in prostaglandin E receptor EP4-knockout mice. J. Biol. Chem. 275, 19819-19823
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 19819-19823
-
-
Miyaura, C.1
Inada, M.2
Suzawa, T.3
Sugimoto, Y.4
Ushikubi, F.5
Ichikawa, A.6
Narumiya, S.7
Suda, T.8
-
25
-
-
0034455647
-
The role of prostaglandin e receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: An analysis using specific agonists for the respective EPs
-
Suzawa, T., Miyaura, C., Inada, M., Maruyama, T., Sugimoto, Y., Ushikubi, F., Ichikawa, A., Narumiya, S., and Suda, T. (2000) The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology 141, 1554-1559
-
(2000)
Endocrinology
, vol.141
, pp. 1554-1559
-
-
Suzawa, T.1
Miyaura, C.2
Inada, M.3
Maruyama, T.4
Sugimoto, Y.5
Ushikubi, F.6
Ichikawa, A.7
Narumiya, S.8
Suda, T.9
-
26
-
-
0032495992
-
Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice
-
Segi, E., Sugimoto, Y., Yamasaki, A., Aze, Y., Oida, H., Nishimura, T., Murata, T., Matsuoka, T., Ushikubi, F., Hirose, M., Tanaka, T., Yoshida, N., Narumiya, S., and Ichikawa, A. (1998) Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. Biochem. Biophys. Res. Commun. 246, 7-12
-
(1998)
Biochem. Biophys. Res. Commun.
, vol.246
, pp. 7-12
-
-
Segi, E.1
Sugimoto, Y.2
Yamasaki, A.3
Aze, Y.4
Oida, H.5
Nishimura, T.6
Murata, T.7
Matsuoka, T.8
Ushikubi, F.9
Hirose, M.10
Tanaka, T.11
Yoshida, N.12
Narumiya, S.13
Ichikawa, A.14
-
27
-
-
0029088925
-
Endogenous bone-resorbing factors in estrogen deficiency: Cooperative effects of IL-1 and IL-6
-
Miyaura, C., Kusano, K., Masuzawa, T., Chaki, O., Onoe, Y., Aoyagi, M., Sasaki, T., Tamura, T., Koishihara, Y., and Ohsugi, Y. (1995) Endogenous bone-resorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6. J. Bone Miner. Res. 10, 1365-1373
-
(1995)
J. Bone Miner. Res.
, vol.10
, pp. 1365-1373
-
-
Miyaura, C.1
Kusano, K.2
Masuzawa, T.3
Chaki, O.4
Onoe, Y.5
Aoyagi, M.6
Sasaki, T.7
Tamura, T.8
Koishihara, Y.9
Ohsugi, Y.10
-
28
-
-
84866307571
-
Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling
-
Li, H. J., Reinhardt, F., Herschman, H. R., and Weinberg, R. A. (2012) Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling. Cancer Discov. 2, 840-855
-
(2012)
Cancer Discov.
, vol.2
, pp. 840-855
-
-
Li, H.J.1
Reinhardt, F.2
Herschman, H.R.3
Weinberg, R.A.4
-
29
-
-
84860728326
-
Targeted therapies in breast cancer
-
Wicki, A., and Rochlitz, C. (2012) Targeted therapies in breast cancer. Swiss Med. Wkly. 142, w13550
-
(2012)
Swiss Med. Wkly.
, vol.142
, pp. w13550
-
-
Wicki, A.1
Rochlitz, C.2
-
30
-
-
84859394518
-
Interaction between head and neck squamous cell carcinoma cells and fibroblasts in the biosynthesis of PGE2
-
Alcolea, S., Antón, R., Camacho, M., Soler, M., Alfranca, A., Avilés-Jurado, F. X., Redondo, J. M., Quer, M., León, X., and Vila, L. (2012) Interaction between head and neck squamous cell carcinoma cells and fibroblasts in the biosynthesis of PGE2. J. Lipid Res. 53, 630-642
-
(2012)
J. Lipid Res.
, vol.53
, pp. 630-642
-
-
Alcolea, S.1
Antón, R.2
Camacho, M.3
Soler, M.4
Alfranca, A.5
Avilés-Jurado, F.X.6
Redondo, J.M.7
Quer, M.8
León, X.9
Vila, L.10
-
31
-
-
84887938406
-
Melanoma's connections to the tumour microenvironment
-
Brandner, J. M., and Haass, N. K. (2013) Melanoma's connections to the tumour microenvironment. Pathology 45, 443-452
-
(2013)
Pathology
, vol.45
, pp. 443-452
-
-
Brandner, J.M.1
Haass, N.K.2
-
32
-
-
84925496222
-
Cx43 and mechanotransduction in bone
-
Plotkin, L. I., Speacht, T. L., and Donahue, H. J. (2015) Cx43 and mechanotransduction in bone. Curr. Osteoporos. Rep. 13, 67-72
-
(2015)
Curr. Osteoporos. Rep.
, vol.13
, pp. 67-72
-
-
Plotkin, L.I.1
Speacht, T.L.2
Donahue, H.J.3
-
33
-
-
44649137303
-
Genetic deletion of mPGES-1 accelerates intestinal tumorigenesis in APC (Min/+) mice
-
Elander, N., Ungerbäck, J., Olsson, H., Uematsu, S., Akira, S., and Söderkvist, P. (2008) Genetic deletion of mPGES-1 accelerates intestinal tumorigenesis in APC (Min/+) mice. Biochem. Biophys. Res. Commun. 372, 249-253
-
(2008)
Biochem. Biophys. Res. Commun.
, vol.372
, pp. 249-253
-
-
Elander, N.1
Ungerbäck, J.2
Olsson, H.3
Uematsu, S.4
Akira, S.5
Söderkvist, P.6
-
34
-
-
44849085464
-
Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis
-
Nakanishi, M., Montrose, D. C., Clark, P., Nambiar, P. R., Belinsky, G. S., Claffey, K. P., Xu, D., and Rosenberg, D. W. (2008) Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis. Cancer Res. 68, 3251-3259
-
(2008)
Cancer Res.
, vol.68
, pp. 3251-3259
-
-
Nakanishi, M.1
Montrose, D.C.2
Clark, P.3
Nambiar, P.R.4
Belinsky, G.S.5
Claffey, K.P.6
Xu, D.7
Rosenberg, D.W.8
-
35
-
-
73249123772
-
Microsomal prostaglandin e synthase 1 determines tumor growth in vivo of prostate and lung cancer cells
-
Hanaka, H., Pawelzik, S. C., Johnsen, J. I., Rakonjac, M., Terawaki, K., Rasmuson, A., Sveinbjörnsson, B., Schumacher, M. C., Hamberg, M., Samuelsson, B., Jakobsson, P. J., Kogner, P., and Rådmark, O. (2009) Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells. Proc. Natl. Acad. Sci. U.S.A. 106, 18757-18762
-
(2009)
Proc. Natl. Acad. Sci. U.S.A.
, vol.106
, pp. 18757-18762
-
-
Hanaka, H.1
Pawelzik, S.C.2
Johnsen, J.I.3
Rakonjac, M.4
Terawaki, K.5
Rasmuson, A.6
Sveinbjörnsson, B.7
Schumacher, M.C.8
Hamberg, M.9
Samuelsson, B.10
Jakobsson, P.J.11
Kogner, P.12
Rådmark, O.13
-
36
-
-
77956919849
-
Prostaglandin E2/EP1 signaling pathway enhances intercellular adhesion molecule 1 (ICAM-1) expression and cell motility in oral cancer cells
-
Yang, S. F., Chen, M. K., Hsieh, Y. S., Chung, T. T., Hsieh, Y. H., Lin, C. W., Su, J. L., Tsai, M. H., and Tang, C. H. (2010) Prostaglandin E2/EP1 signaling pathway enhances intercellular adhesion molecule 1 (ICAM-1) expression and cell motility in oral cancer cells. J. Biol. Chem. 285, 29808-29816
-
(2010)
J. Biol. Chem.
, vol.285
, pp. 29808-29816
-
-
Yang, S.F.1
Chen, M.K.2
Hsieh, Y.S.3
Chung, T.T.4
Hsieh, Y.H.5
Lin, C.W.6
Su, J.L.7
Tsai, M.H.8
Tang, C.H.9
-
37
-
-
77951157434
-
Prostaglandin E2 promotes lung cancer cell migration via EP4-bArrestin1-c-Src signalsome
-
Kim, J. I., Lakshmikanthan, V., Frilot, N., and Daaka, Y. (2010) Prostaglandin E2 promotes lung cancer cell migration via EP4-bArrestin1-c-Src signalsome. Mol. Cancer Res. 8, 569-577
-
(2010)
Mol. Cancer Res.
, vol.8
, pp. 569-577
-
-
Kim, J.I.1
Lakshmikanthan, V.2
Frilot, N.3
Daaka, Y.4
-
38
-
-
54249155141
-
Prostaglandin E2 regulates tumor angiogenesis in prostate cancer
-
Jain, S., Chakraborty, G., Raja, R., Kale, S., and Kundu, G. C. (2008) Prostaglandin E2 regulates tumor angiogenesis in prostate cancer. Cancer Res. 68, 7750-7759
-
(2008)
Cancer Res.
, vol.68
, pp. 7750-7759
-
-
Jain, S.1
Chakraborty, G.2
Raja, R.3
Kale, S.4
Kundu, G.C.5
-
39
-
-
33750308463
-
Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism
-
Yang, L., Huang, Y., Porta, R., Yanagisawa, K., Gonzalez, A., Segi, E., Johnson, D. H., Narumiya, S., and Carbone, D. P. (2006) Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism. Cancer Res. 66, 9665-9672
-
(2006)
Cancer Res.
, vol.66
, pp. 9665-9672
-
-
Yang, L.1
Huang, Y.2
Porta, R.3
Yanagisawa, K.4
Gonzalez, A.5
Segi, E.6
Johnson, D.H.7
Narumiya, S.8
Carbone, D.P.9
-
40
-
-
84862809842
-
Denosumab in patients with cancer - A surgical strike against the osteoclast
-
Brown, J. E., and Coleman, R. E. (2012) Denosumab in patients with cancer-a surgical strike against the osteoclast. Nat. Rev. Clin. Oncol. 9, 110-118
-
(2012)
Nat. Rev. Clin. Oncol.
, vol.9
, pp. 110-118
-
-
Brown, J.E.1
Coleman, R.E.2
-
41
-
-
35349022651
-
Prostaglandin E2 stimulates VEGF expression in primary rat gastric fibroblasts through EP4 receptors
-
Hatazawa, R., Tanigami, M., Izumi, N., Kamei, K., Tanaka, A., and Takeuchi, K. (2007) Prostaglandin E2 stimulates VEGF expression in primary rat gastric fibroblasts through EP4 receptors. Inflammopharmacology 15, 214-217
-
(2007)
Inflammopharmacology
, vol.15
, pp. 214-217
-
-
Hatazawa, R.1
Tanigami, M.2
Izumi, N.3
Kamei, K.4
Tanaka, A.5
Takeuchi, K.6
-
42
-
-
50349101081
-
Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer
-
Guo, X., Oshima, H., Kitmura, T., Taketo, M. M., and Oshima, M. (2008) Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer. J. Biol. Chem. 283, 19864-19871
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 19864-19871
-
-
Guo, X.1
Oshima, H.2
Kitmura, T.3
Taketo, M.M.4
Oshima, M.5
-
43
-
-
0031038068
-
Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor β-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis
-
Relf, M., LeJeune, S., Scott, P. A., Fox, S., Smith, K., Leek, R., Moghaddam, A., Whitehouse, R., Bicknell, R., and Harris, A. L. (1997) Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor β-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res. 57, 963-969
-
(1997)
Cancer Res.
, vol.57
, pp. 963-969
-
-
Relf, M.1
LeJeune, S.2
Scott, P.A.3
Fox, S.4
Smith, K.5
Leek, R.6
Moghaddam, A.7
Whitehouse, R.8
Bicknell, R.9
Harris, A.L.10
-
44
-
-
0032858954
-
Evidence for a role of FGF-2 and FGF receptors in the proliferation of non-small cell lung cancer cells
-
Berger, W., Setinek, U., Mohr, T., Kindas-Mügge, I., Vetterlein, M., Dekan, G., Eckersberger, F., Caldas, C., and Micksche, M. (1999) Evidence for a role of FGF-2 and FGF receptors in the proliferation of non-small cell lung cancer cells. Int. J. Cancer. 83, 415-423
-
(1999)
Int. J. Cancer.
, vol.83
, pp. 415-423
-
-
Berger, W.1
Setinek, U.2
Mohr, T.3
Kindas-Mügge, I.4
Vetterlein, M.5
Dekan, G.6
Eckersberger, F.7
Caldas, C.8
Micksche, M.9
-
45
-
-
0032954333
-
Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer
-
Giri, D., Ropiquet, F., and Ittmann, M. (1999) Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer. Clin. Cancer Res. 5, 1063-1071
-
(1999)
Clin. Cancer Res.
, vol.5
, pp. 1063-1071
-
-
Giri, D.1
Ropiquet, F.2
Ittmann, M.3
-
46
-
-
0141731322
-
Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer
-
Polnaszek, N., Kwabi-Addo, B., Peterson, L. E., Ozen, M., Greenberg, N. M., Ortega, S., Basilico, C., and Ittmann, M. (2003) Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer. Cancer Res. 63, 5754-5760
-
(2003)
Cancer Res.
, vol.63
, pp. 5754-5760
-
-
Polnaszek, N.1
Kwabi-Addo, B.2
Peterson, L.E.3
Ozen, M.4
Greenberg, N.M.5
Ortega, S.6
Basilico, C.7
Ittmann, M.8
-
47
-
-
38349183605
-
Prostaglandin E2 regulates angiogenesis via activation of fibroblast growth factor receptor-1
-
Finetti, F., Solito, R., Morbidelli, L., Giachetti, A., Ziche, M., and Donnini, S. (2008) Prostaglandin E2 regulates angiogenesis via activation of fibroblast growth factor receptor-1. J. Biol. Chem. 283, 2139-2146
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 2139-2146
-
-
Finetti, F.1
Solito, R.2
Morbidelli, L.3
Giachetti, A.4
Ziche, M.5
Donnini, S.6
-
48
-
-
34447135497
-
Prostaglandin E2-EP4 receptor promotes endothelial cell migration via ERK activation and angiogenesis in vivo
-
Rao, R., Redha, R., Macias-Perez, I., Su, Y., Hao, C., Zent, R., Breyer, M. D., and Pozzi, A. (2007) Prostaglandin E2-EP4 receptor promotes endothelial cell migration via ERK activation and angiogenesis in vivo. J. Biol. Chem. 282, 16959-16968
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 16959-16968
-
-
Rao, R.1
Redha, R.2
Macias-Perez, I.3
Su, Y.4
Hao, C.5
Zent, R.6
Breyer, M.D.7
Pozzi, A.8
|